Lexicon Pharmaceuticals
LXRX
LXRX
94 hedge funds and large institutions have $802M invested in Lexicon Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
21% less funds holding
Funds holding: 119 → 94 (-25)
60% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 40
Holders
94
Holding in Top 10
3
Calls
$22K
Puts
$16K
Top Buyers
| 1 | +$8.07M | |
| 2 | +$2.09M | |
| 3 | +$1.67M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.07M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$842K |
Top Sellers
| 1 | -$3.61M | |
| 2 | -$3.07M | |
| 3 | -$2.9M | |
| 4 |
AGC
Alden Global Capital
Brandon,
Florida
|
-$851K |
| 5 |
TCT
TIAA CREF Trust
St Louis,
Missouri
|
-$760K |